ClinicalTrials.Veeva

Menu

Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

Mayo Clinic logo

Mayo Clinic

Status

Active, not recruiting

Conditions

Osteoarthritis Foot
Osteoarthritis Ankle

Treatments

Device: Electromagnetic Transduction Therapy (EMTT)

Study type

Interventional

Funder types

Other

Identifiers

NCT06696118
24-002661

Details and patient eligibility

About

The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Men and women with osteoarthritis of the foot and/or ankle confirmed via radiographs.

Exclusion criteria

• Pacemaker, active cancer, shrapnel, metal in eye, implantable devices that are not compatible with MRIs, concurrent foot or ankle condition or injury, prior foot or ankle surgery for osteoarthritis, steroid, platelet rich plasma, or hyaluronic acid injection within 2 months of the treatment.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Mid-foot osteoarthritis
Experimental group
Treatment:
Device: Electromagnetic Transduction Therapy (EMTT)

Trial contacts and locations

1

Loading...

Central trial contact

Jenny D Obst

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems